We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TYRES:OMXHEXNokian Renkaat Oyj Analysis

Data as of 2026-06-14 - not real-time

€11.60

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Nokian Renkaat trades at €11.6, roughly 30% above its DCF‑derived fair value of €8.9, indicating a near‑term overvaluation. Technicals show a bullish MACD crossover and a 20‑day SMA above the 50‑day SMA, but the RSI sits at 68, hinting at possible short‑term exhaustion as the price approaches the resistance around €11.67. The stock’s beta of 0.49 suggests muted market‑wide volatility, yet 30‑day price swings are high at 27%, and volume trends are decreasing, adding liquidity concerns. Fundamentally, revenue grew modestly 3.7% YoY while operating margins remain negative and profit margins are near‑zero, but free cash flow is positive and the dividend yield of 2.16% with a low 13.75% payout ratio points to sustainable income. The balance sheet carries a high debt load (Debt/Equity ~80%) but cash reserves cushion short‑term needs. Geographic diversification across Nordics, Central Europe and North America mitigates regional shocks, while the consumer‑cyclical auto‑parts sector remains sensitive to economic cycles. Overall, the stock sits in a zone of extreme market greed, with upside limited and downside risk tied to earnings improvement and debt management.
Investors should treat the current price as a short‑term premium driven by market sentiment; the longer view favors the company’s stable dividend, low beta and diversified footprint, provided earnings turn positive and leverage is reduced.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Price significantly above DCF fair value
  • High RSI indicating overbought conditions
  • Approaching technical resistance level

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Stabilizing technical indicators
  • Sustainable dividend yield
  • Need for earnings and margin improvement

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Low beta and defensive dividend profile
  • Geographic diversification reducing regional risk
  • Potential upside from debt reduction and margin recovery

Key Metrics & Analysis

Financial Health

Revenue Growth3.70%
Profit Margin0.04%
P/E Ratio14.7
ROE0.05%
ROA1.40%
Debt/Equity79.64
P/B Ratio1.4
Op. Cash Flow€196.6M
Free Cash Flow€127.8M

Technical Analysis

TrendBullish
RSI68.2
Support€10.16
Resistance€11.67
MA 20€10.86
MA 50€10.32
MA 200€9.43
MACDBullish
VolumeDecreasing
Fear & Greed Index89.86

Valuation

Fair Value€8.90
Target Price€9.71
Upside/Downside-16.27%
GradeOvervalued
TypeValue
Dividend Yield2.16%

Risk Assessment

Beta0.49
Volatility27.03%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.